Ā | Post-bronchodilator [Mean (95Ā % CI)] | Ā | ||
---|---|---|---|---|
FEV1 % predicted | FVC % predicted | FEV1: FVC (%) | FEV1 reversibility (%) | |
All subjects (nā=ā221) | ||||
ālow | 81.4 (75.6ā87.2) | 99.5 (92.4ā106.5) | 64.6 (61.9ā67.2) | 8.4 (6.5ā10.3) |
āmedium | 75.7 (70.7ā80.7) | 93.7 (87.7ā99.8) | 62.1 (59.8ā64.3) | 8.9 (7.1ā10.7) |
āhigh | 70.9* (66.5ā75.3) | 93.8 (88.4ā99.1) | 59.8* (57.8ā61.8) | 10.9 (8.9ā13.0) |
Males (nā=ā150) | ||||
ālow | 80.3 (73.6ā87.0) | 95.6 (89.6ā101.7) | 64.1 (60.6ā67.7) | 8.5 (6.3ā10.8) |
āmedium | 78.0 (73.0ā83.1) | 94.4 (89.8ā99.0) | 62.2 (59.6ā64.9) | 8.8 (6.9ā10.6) |
āhigh | 71.9* (66.7ā77.1) | 93.2 (88.5ā98.0) | 58.9* (56.1ā61.6) | 10.6 (7.9ā13.3) |
Females (nā=ā71) | ||||
ālow | 80.5 (69.7ā91.2) | 103.8 (86.7ā120.9) | 64.6 (60.6ā68.6) | 8.2 (4.6ā11.7) |
āmedium | 69.7 (55.8ā83.6) | 93.6 (71.5ā115.7) | 61.9 (56.7ā67.0) | 9.4 (4.5ā14.3) |
āhigh | 69.1# (61.4ā76.8) | 94.9 (82.7ā107.2) | 61.3 (58.5ā64.2) | 11.5 (8.3ā14.6) |